Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients With Refractory, Locally Advanced or Metastatic Solid Tumors
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-2745
Full Text
Open PDFAbstract
Available in full text
Date
February 7, 2011
Authors
Publisher
American Association for Cancer Research (AACR)